搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The News Today
3 分钟
Heart muscle can regenerate after failure in some people with artificial hearts: Study
Heart muscle can regenerate after failure in some people with artificial hearts, an international research team has found.
eLife
7 天
Visualizing sarcomere and cellular dynamics in skeletal muscle to improve cell therapies
Titin’s regulated integration and mobility after cell fusion support syncytium formation in culture, while limited diffusion in vivo highlights a key challenge for developing effective cell-based ...
ConsumerAffairs
6 天
Skeletal muscle loss as you age may raise dementia risk
Dementia, which can affect people as they age, may have many different causes or contributors. A recent study presented at ...
earth
1 天
Heart muscles may soon be able to regenerate like other muscles
A study reveals artificial hearts can regenerate heart muscle cells, supporting the idea that resting the heart enables ...
2 天
on MSN
The Size Of This Muscle Has Been Linked To Dementia Risk
And now, a study from researchers at several Johns Hopkins Medical Institutions has found that the size of one particular ...
1 天
on MSN
Unexpected heart muscle growth found in patients with artificial hearts
A research team co-led by a physician-scientist at the University of Arizona College of Medicine—Tucson's Sarver Heart Center ...
english.mathrubhumi
20 小时
Heart muscle can regenerate after failure in some patients with artificial hearts: Study
A groundbreaking study has revealed that heart muscle can regenerate in certain patients with artificial hearts, offering new ...
emjreviews.com
13 天
MRI Links Muscle Loss to Early Dementia Risk in Older Adults: RSNA 2024
NEW research unveiled at the Radiological Society of North America (RSNA) meeting on 3rd December 2024 has revealed that ...
FierceBiotech
6 天
Edgewise's skeletal myosin inhibitor reduces biomarker in phase 2 muscular dystrophy trial
Edgewise Therapeutics’ lead candidate has been shown to reduce levels of a biomarker related to skeletal muscle damage in a ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈